IN8BIO, INC. Investing Cash Flow
IN8BIO, INC. (INAB) reported Investing Cash Flow of -$242.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- IN8BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$233.00K.
- IN8BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$9.00K.
- IN8BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $0.00.
- IN8BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00.
- IN8BIO, INC. net cash provided by (used in) investing activities for fiscal 2025 was $0.00.
- IN8BIO, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$187.00K.
- IN8BIO, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$600.00K.
- IN8BIO, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$3.71M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$233.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$242.00K 10-Q · filed 2026-08-06 | -$242.00K derived: sum of 3 quarters · filed 2026-08-06 | -$242.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$9.00K 10-Q · filed 2026-05-07 | -$9.00K derived: sum of 2 quarters · filed 2026-05-07 | -$9.00K derived: sum of 3 quarters · filed 2026-05-07 | -$9.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 10-Q · filed 2025-11-06 | -$33.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | -$33.00K derived: sum of 3 quarters · filed 2026-08-06 | -$33.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | -$33.00K derived: sum of 2 quarters · filed 2026-05-07 | -$33.00K derived: sum of 3 quarters · filed 2026-05-07 | -$116.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$33.00K derived: sum of 2 quarters · filed 2026-03-12 | -$116.00K derived: sum of 3 quarters · filed 2026-03-12 | -$187.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$83.00K derived: sum of 2 quarters · filed 2025-11-06 | -$154.00K 10-Q · filed 2025-11-06 | -$226.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$154.00K 10-Q · filed 2025-08-07 | -$226.00K derived: sum of 3 quarters · filed 2025-08-07 | -$303.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$71.00K 10-Q · filed 2025-05-07 | -$143.00K derived: sum of 2 quarters · filed 2025-05-07 | -$220.00K derived: sum of 3 quarters · filed 2025-05-07 | -$242.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$149.00K derived: sum of 2 quarters · filed 2025-03-13 | -$171.00K derived: sum of 3 quarters · filed 2025-03-13 | -$600.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | -$77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$99.00K derived: sum of 2 quarters · filed 2024-11-12 | -$528.00K 10-Q · filed 2024-11-12 | -$1.79M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$451.00K 10-Q · filed 2024-08-08 | -$1.71M derived: sum of 3 quarters · filed 2024-08-08 | -$3.48M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$429.00K 10-Q · filed 2024-05-09 | -$1.69M derived: sum of 2 quarters · filed 2024-05-09 | -$3.46M derived: sum of 3 quarters · filed 2024-05-09 | -$3.88M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$3.03M derived: sum of 2 quarters · filed 2024-03-14 | -$3.45M derived: sum of 3 quarters · filed 2024-03-14 | -$3.71M 10-K · filed 2024-03-14 |
| 2022-09-30 | -$1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$2.19M derived: sum of 2 quarters · filed 2023-11-09 | -$2.44M 10-Q · filed 2023-11-09 | -$2.60M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$425.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$678.00K 10-Q · filed 2023-08-10 | -$834.00K derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$253.00K 10-Q · filed 2023-05-12 | -$409.00K derived: sum of 2 quarters · filed 2023-05-12 | ||
| 2021-12-31 | -$156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$309.00K 10-K · filed 2023-03-30 | ||
| 2021-09-30 | -$153.00K 10-Q · filed 2022-11-10 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 10-K · filed 2022-03-17 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |